Finance

Lists
Why is 600572 down 2.07%?
Dive Deeper
600572:SHA
Zhejiang CONBA Pharmaceutical Co., Ltd.
CNÂ¥4.26
-2.07%
(-0.090) 1D
Nov 6, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600572...
Open
CNÂ¥4.30
High
CNÂ¥4.30
Low
CNÂ¥4.21
Mkt. cap
11.05B
Avg. vol.
42.10M
Volume
45.41M
Dividend
3.52%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
23.94
52-wk high
CNÂ¥5.17
52-wk low
CNÂ¥3.77
EPS
CNÂ¥0.18
Shares outstanding
2.67B
No. of employees
8K
Open
CNÂ¥4.30
High
CNÂ¥4.30
Low
CNÂ¥4.21
Mkt. cap
11.05B
Avg. vol.
42.10M
Volume
45.41M
Dividend
3.52%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
23.94
52-wk high
CNÂ¥5.17
52-wk low
CNÂ¥3.77
EPS
CNÂ¥0.18
Shares outstanding
2.67B
No. of employees
8K
News stories
From web sources and news partners
About Zhejiang CONBA Pharmaceutical Co., Ltd.
CEO-
Employees7.83K
Founded1969
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.50B
1.91B
1.80B
1.63B
Cost of goods sold
751.67M
824.28M
786.71M
725.13M
Cost of revenue
751.67M
824.28M
786.71M
725.13M
Research and development expenses
78.49M
49.23M
62.51M
50.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
611.75M
751.80M
688.94M
630.94M
Operating expense
701.12M
825.90M
777.06M
706.96M
Total operating expenses
1.45B
1.65B
1.56B
1.43B
Operating income
45.06M
255.33M
231.98M
196.61M
Other non operating income
-234.68K
-4.03M
1.79M
-9.32M
EBT including unusual items
-51.57M
249.08M
225.65M
225.46M
EBT excluding unusual items
67.42M
266.37M
255.44M
220.97M
Income tax expense
53.06M
46.05M
40.26M
31.08M
Effective tax rate
-102.87%
18.49%
17.84%
13.78%
Other operating expenses
13.93M
22.15M
21.98M
22.33M
Net income
-109.67M
198.45M
179.32M
188.64M
Net profit margin
-7.32%
10.41%
9.99%
11.58%
Earnings per share
-
-
-
-
Interest and investment income
26.12M
4.64M
41.65M
26.56M
Interest expense
-1.77M
-1.50M
-528.12K
-410.68K
Net interest expenses
24.35M
3.14M
41.13M
26.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
128.05M
338.33M
314.43M
279.61M
Gain or loss from assets sale
-4.89M
-
-522.49K
522.49K
Upcoming events
AI content may include mistakes. Learn more
Google apps